- call +1-201-465-4211
- email sales@mrinsights.biz
The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.
Scope of the Report:
Based on classification, the proportion of Viral Vectors Manufacturing in 2016 is about 79.74%, with revenue about 200 M USD. Based on application, Cancers segment accounted for larger market share in terms of sales in 2016, vascular segmented accounted for more than 61% of the market share in 2016.
North America is the largest consumption place, with a consumption market share nearly 51% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 34% in 2016.
Market competition is intense among top 5. BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Viral Vectors and Plasmid DNA Manufacturing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Viral Vectors and Plasmid DNA Manufacturing.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Viral Vectors and Plasmid DNA Manufacturing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Viral Vectors and Plasmid DNA Manufacturing market by product type and applications/end industries.
Market Segment by Companies, this report covers
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
VGXI
PlasmidFactory
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Plasmid DNA
Viral Vectors
Market Segment by Applications, can be divided into
Cancers
Inherited Disorders
Viral Infections
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Viral Vectors and Plasmid DNA Manufacturing Market Overview
1.1 Product Overview and Scope of Viral Vectors and Plasmid DNA Manufacturing
1.2 Classification of Viral Vectors and Plasmid DNA Manufacturing by Types
1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Comparison by Types (2019-2024)
1.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Types in 2018
1.2.3 Plasmid DNA
1.2.4 Viral Vectors
1.3 Global Viral Vectors and Plasmid DNA Manufacturing Market by Application
1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Global Viral Vectors and Plasmid DNA Manufacturing Market by Regions
1.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2014-2024)
1.5 Global Market Size of Viral Vectors and Plasmid DNA Manufacturing (2014-2024)
2 Manufacturers Profiles
2.1 BioReliance
2.1.1 Business Overview
2.1.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.2 Cobra Biologics
2.2.1 Business Overview
2.2.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.3 Oxford BioMedica
2.3.1 Business Overview
2.3.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.4 UniQure
2.4.1 Business Overview
2.4.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.5 FinVector
2.5.1 Business Overview
2.5.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.6 MolMed
2.6.1 Business Overview
2.6.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.7 MassBiologics
2.7.1 Business Overview
2.7.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.8 Richter-Helm
2.8.1 Business Overview
2.8.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.9 FUJIFILM Diosynth Biotechnologies
2.9.1 Business Overview
2.9.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.10 Lonza
2.10.1 Business Overview
2.10.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.11 Aldevron
2.11.1 Business Overview
2.11.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.12 Eurogentec
2.12.1 Business Overview
2.12.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.13 Cell and Gene Therapy Catapult
2.13.1 Business Overview
2.13.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.14 Biovian
2.14.1 Business Overview
2.14.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.15 Brammer Bio
2.15.1 Business Overview
2.15.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.16 VGXI
2.16.1 Business Overview
2.16.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
2.17 PlasmidFactory
2.17.1 Business Overview
2.17.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
3 Global Viral Vectors and Plasmid DNA Manufacturing Market Competition, by Players
3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Viral Vectors and Plasmid DNA Manufacturing Players Market Share
3.2.2 Top 10 Viral Vectors and Plasmid DNA Manufacturing Players Market Share
3.3 Market Competition Trend
4 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Regions
4.2 North America Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
4.3 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
4.5 South America Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
5 North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries
5.1 North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2014-2019)
5.2 USA Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
5.3 Canada Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
5.4 Mexico Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
6 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries
6.1 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2014-2019)
6.2 Germany Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
6.3 UK Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
6.4 France Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
6.5 Russia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
6.6 Italy Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries
7.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2014-2019)
7.2 China Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
7.3 Japan Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
7.4 Korea Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
7.5 India Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
8 South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries
8.1 South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2014-2019)
8.2 Brazil Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
8.3 Argentina Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
8.4 Colombia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Viral Vectors and Plasmid DNA Manufacturing by Countries
9.1 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2014-2019)
9.2 Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
9.3 UAE Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
9.4 Egypt Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
9.5 Nigeria Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
9.6 South Africa Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
10 Global Viral Vectors and Plasmid DNA Manufacturing Market Segment by Type
10.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Type (2014-2019)
10.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Type (2019-2024)
10.3 Plasmid DNA Revenue Growth Rate (2014-2024)
10.4 Viral Vectors Revenue Growth Rate (2014-2024)
11 Global Viral Vectors and Plasmid DNA Manufacturing Market Segment by Application
11.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2014-2019)
11.2 Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application (2019-2024)
11.3 Cancers Revenue Growth (2014-2019)
11.4 Inherited Disorders Revenue Growth (2014-2019)
11.5 Viral Infections Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast (2019-2024)
12.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast (2019-2024)
12.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Regions (2019-2024)
12.3 North America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2019-2024)
12.4 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2019-2024)
12.6 South America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Viral Vectors and Plasmid DNA Manufacturing Picture
Table Product Specifications of Viral Vectors and Plasmid DNA Manufacturing
Table Global Viral Vectors and Plasmi
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
